SECURITIES AND EXCHANGE COMMISSIONS
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) February 27, 2001
-------------------------------
ICU MEDICAL, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-19974 33-0022692
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
951 Calle Amanecer San Clemente, California 92673
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (949) 366-2183
----------------------------
N/A
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events
- ------- ------------
On February 27, 2001, ICU Medical, Inc. and Abbott Laboratories signed
the following agreement, as further described in the press release filed as
Exhibit 2 hereto: "Co-Promotion and Distribution Agreement Between ICU Medical,
Inc. and Abbott Laboratories."
Item 7. Financial Statements and Exhibits
- ------- ---------------------------------
(c) Exhibits
1. CO-PROMOTION AND DISTRIBUTION AGREEMENT, dated as of February
27, 2001.
2. Press release, dated February 28, 2001, announcing expansion
of contract with Abbott Laboratories.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be filed on its behalf by the
undersigned hereunto duly authorized.
Date: March 7, 2001
ICU MEDICAL, INC.
By: /S/ Francis J. O'Brien
--------------------------
Francis J. O'Brien
Secretary, Treasurer and
Chief Financial Officer